See more : Shufersal Ltd (SHUFF) Income Statement Analysis – Financial Results
Complete financial analysis of PT Duta Intidaya Tbk (DAYA.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Duta Intidaya Tbk, a leading company in the Specialty Retail industry within the Consumer Cyclical sector.
- Baoji Titanium Industry Co., Ltd. (600456.SS) Income Statement Analysis – Financial Results
- OptimumBank Holdings, Inc. (OPHC) Income Statement Analysis – Financial Results
- Quhuo Limited (QH) Income Statement Analysis – Financial Results
- Shandong Sinocera Functional Material Co., Ltd. (300285.SZ) Income Statement Analysis – Financial Results
- New Century Healthcare Holding Co. Limited (1518.HK) Income Statement Analysis – Financial Results
PT Duta Intidaya Tbk (DAYA.JK)
About PT Duta Intidaya Tbk
PT Duta Intidaya Tbk operates as a health and beauty retailer in Indonesia. The company offers medicines, pharmacy goods, medical and wellness equipment, personal and skin care products, perfumes and cosmetics, baby products, and general merchandise in stores and/or pharmacies. It also trades in food and beverages. In addition, the company acts as an agent/representative, sole agent, distributor, and purveyor, as well as a franchise and supplier of various traded goods. As of December 31, 2021, the company operated a network of 160 stores in 14 provinces under the Watsons brand. It also operates online stores at Shopee.com, Tokopedia. com, Lazada.com, Blibli.com, and Bukalapak.com marketplace, as well as Halodoc, Bima+ app, Good Doctor app, GrabMart app, and GoMart app. The company was founded in 2005 and is based in South Jakarta, Indonesia. PT Duta Intidaya Tbk is a subsidiary of Total Alliance Holdings Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,546.00B | 1,161.59B | 971.30B | 886.24B | 1,094.84B | 547.32B | 363.68B | 237.50B | 192.42B | 163.38B | 124.38B |
| Cost of Revenue | 1,067.51B | 862.98B | 724.29B | 665.00B | 799.21B | 319.82B | 211.33B | 144.87B | 119.99B | 93.34B | 73.39B |
| Gross Profit | 478.49B | 298.61B | 247.01B | 221.24B | 295.63B | 227.51B | 152.36B | 92.63B | 72.42B | 70.04B | 50.99B |
| Gross Profit Ratio | 30.95% | 25.71% | 25.43% | 24.96% | 27.00% | 41.57% | 41.89% | 39.00% | 37.64% | 42.87% | 41.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 10.53B | 8.46B | 6.36B | 11.41B | 10.65B | 8.12B | 5.30B | 3.40B | 5.28B | 3.09B | 2.10B |
| Selling & Marketing | 67.48B | 41.08B | 23.98B | 15.10B | 19.39B | 13.27B | 6.67B | 2.46B | 2.56B | 2.62B | 2.65B |
| SG&A | 329.75B | 308.07B | 258.13B | 244.87B | 267.34B | 222.32B | 155.31B | 112.06B | 92.51B | 36.12B | 25.42B |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 329.75B | 308.07B | 258.13B | 244.87B | 267.34B | 222.32B | 155.31B | 112.06B | 92.51B | 87.93B | 71.49B |
| Cost & Expenses | 1,397.26B | 1,171.05B | 982.42B | 909.88B | 1,066.55B | 542.13B | 366.64B | 256.93B | 212.50B | 181.27B | 144.88B |
| Interest Income | 2.51B | 883.06M | 1.12B | 917.80M | 1.09B | 2.98B | 1.25B | 1.11B | 168.46M | 4.47B | 2.53B |
| Interest Expense | 21.74B | 28.10B | 31.89B | 22.66B | 18.11B | 3.36B | 2.05B | 2.81B | 6.45B | 0.00 | 0.00 |
| Depreciation & Amortization | 45.90B | 130.66B | 119.78B | 110.00B | 82.08B | 16.17B | 13.32B | 11.93B | 9.02B | 7.06B | 3.76B |
| EBITDA | 58.17B | 121.19B | 104.25B | 86.37B | 110.36B | 21.37B | 10.36B | -7.51B | -11.07B | 28.73B | 20.84B |
| EBITDA Ratio | 3.76% | 10.43% | 11.19% | 9.75% | 10.08% | 3.90% | 2.85% | -3.16% | -5.75% | 17.59% | 16.75% |
| Operating Income | 148.74B | -9.46B | -11.12B | -23.63B | 28.29B | 5.19B | -2.96B | -19.43B | -20.09B | 21.67B | 17.07B |
| Operating Income Ratio | 9.62% | -0.81% | -1.15% | -2.67% | 2.58% | 0.95% | -0.81% | -8.18% | -10.44% | 13.26% | 13.73% |
| Total Other Income/Expenses | -156.39B | -29.47B | -36.29B | -22.35B | -15.64B | -2.74B | -770.62M | -4.15B | -10.74B | -56.29B | -48.61B |
| Income Before Tax | -7.65B | -38.94B | -47.42B | -45.98B | 12.65B | 2.45B | -3.73B | -23.59B | -30.83B | -22.36B | -23.03B |
| Income Before Tax Ratio | -0.49% | -3.35% | -4.88% | -5.19% | 1.15% | 0.45% | -1.02% | -9.93% | -16.02% | -13.69% | -18.51% |
| Income Tax Expense | 8.54B | 1.09B | 4.29B | 2.83B | -5.89B | -2.75B | 255.20M | 543.57M | 4.42B | 252.13M | 127.26M |
| Net Income | -16.19B | -40.02B | -51.71B | -48.82B | 18.54B | 5.20B | -3.98B | -24.13B | -35.25B | -22.61B | -23.15B |
| Net Income Ratio | -1.05% | -3.45% | -5.32% | -5.51% | 1.69% | 0.95% | -1.09% | -10.16% | -18.32% | -13.84% | -18.62% |
| EPS | -6.69 | -16.53 | -21.36 | -20.17 | 7.66 | 2.15 | -1.90 | -13.03 | -8.10 | -20.34 | -231.54K |
| EPS Diluted | -6.69 | -16.53 | -21.36 | -20.17 | 7.66 | 2.15 | -1.90 | -13.03 | -8.10 | -20.34 | -231.54K |
| Weighted Avg Shares Out | 2.42B | 2.42B | 2.42B | 2.42B | 2.42B | 2.42B | 2.09B | 1.85B | 4.35B | 1.11B | 100.00K |
| Weighted Avg Shares Out (Dil) | 2.42B | 2.42B | 2.42B | 2.42B | 2.42B | 2.42B | 2.09B | 1.85B | 4.35B | 1.11B | 100.00K |
Source: https://incomestatements.info
Category: Stock Reports